Author | Laura Newman, MD

Articles

No consensus: Clinical trials wrestle with role of atropine in treating amblyopia

Baltimore-Amblyopia is a relatively common problem in children, but there is no consensus on the best treatment. Recently, there has been increasing interest in using atropine drops instead of patching, but they are not FDA approved for that indication, said Michael X. Repka, MD.

New content coming soon, please check back later.